Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CRSP

CRISPR Therapeutics AG

May 26 • 04:00PM ET

51.61

+1.25 2.48 %

Healthcare • Biotechnology • Switzerland • Mid • NASD

Peers: NTLA BEAM EDIT PRME VRTX

| Held by: ARKK IWM XBI ARKG VXF IWN IBB VTWO SCHA SCHM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-6.21	Insider Own	7.15%	Shs Outstand	96.39M	Perf Week	6.28%
Market Cap	4.98B	Forward P/E	-	EPS next Y	-3.73	Insider Trans	-3.21%	Shs Float	89.55M	Perf Month	5.79%
Enterprise Value	3.32B	PEG	-	EPS next Q	-1.19	Inst Own	72.72%	Short Float	25.11%	Perf Quarter	-9.09%
Income	-568.53M	P/S	1214.08	EPS this Y	25.26%	Inst Trans	1.52%	Short Ratio	11.77	Perf Half Y	4.71%
Sales	4.10M	P/B	2.74	EPS next Y	22.89%	ROA	-23.24%	Short Interest	22.48M	Perf YTD	-1.58%
Book/sh	18.83	P/C	2.04	EPS next 5Y	29.69%	ROE	-31.21%	52W High	78.48 -34.24%	Perf Year	40.02%
Cash/sh	25.32	P/FCF	-	EPS past 3/5Y	8.21% -4.10%	ROIC	-22.01%	52W Low	35.38 45.87%	Perf 3Y	-20.18%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	43.09% 37.31%	Gross Margin	-5283.40%	Volatility	3.85% 5.28%	Perf 5Y	-56.45%
Dividend TTM	-	EV/Sales	810.53	EPS Y/Y TTM	-37.55%	Oper. Margin	-13408.29%	ATR (14)	2.45	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	17.96	Sales Y/Y TTM	-89.11%	Profit Margin	-13856.54%	RSI (14)	50.60	Recom	1.96
Dividend Gr. 3/5Y	- -	Current Ratio	17.96	EPS Q/Q	19.13%	SMA20	0.21%	Beta	1.72	Target Price	78.45
Payout	-	Debt/Eq	0.43	Sales Q/Q	68.55%	SMA50	1.05%	Rel Volume	0.76	Prev Close	50.36
Employees	-	LT Debt/Eq	0.42	Earnings	May 04 AMC	SMA200	-7.38%	Avg Volume	1.91M	Price	51.61
IPO	Oct 19, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.05% -75.96%	Trades		Volume	1,450,437	Change	2.48%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)